Long-term heavy use of ibuprofen quietly raises the risk of kidney and heart trouble

Ibuprofen is one of the most familiar medicines in the world, sold without a prescription and reached for routinely to treat headaches, sore muscles, arthritis and fevers. Its reputation as a mild, everyday remedy can obscure a well-documented fact in the medical literature: taken at high doses over long periods, ibuprofen and other drugs in its class carry a measurable risk of damage to the kidneys and the cardiovascular system. Regulators have warned about these risks for years, and researchers continue to map how they arise. The hazard is dose-dependent and generally concerns sustained heavy use rather than the occasional tablet, but for people who rely on the drug for chronic pain, it is a real consideration.

How ibuprofen works, and where the trouble begins

Ibuprofen belongs to a family of medicines called nonsteroidal anti-inflammatory drugs, or NSAIDs, which also includes naproxen and prescription drugs such as diclofenac. These medicines relieve pain and inflammation by blocking enzymes called cyclooxygenases, which the body uses to produce signaling molecules called prostaglandins. Prostaglandins drive inflammation and pain, but they also perform quieter housekeeping jobs, including helping to regulate blood flow to the kidneys and maintaining the protective lining of the stomach. Because NSAIDs suppress prostaglandins throughout the body rather than only at a site of injury, their benefits and their harms stem from the same basic action. The tradeoff becomes more consequential the longer and more heavily the drugs are used.

The strain on the kidneys

The kidneys are particularly sensitive to prostaglandin suppression. Prostaglandins help keep the small blood vessels feeding the kidneys open, and when NSAIDs reduce that signaling, blood flow through the kidneys can drop. In a healthy person taking an occasional dose, the effect is usually minor and reversible. In people who take high doses over long periods, or who already have reduced kidney function, the reduction in blood flow can cause acute kidney injury and, with chronic use, contribute to lasting decline. Reviews of the evidence note that the elderly and people with heart failure, liver disease, dehydration, or those taking certain blood-pressure medicines such as diuretics and ACE inhibitors face the greatest danger. Research summarized in the American Journal of Kidney Diseases has examined how NSAID use intersects with existing kidney disease, and analyses have linked daily doses above roughly 1,200 milligrams of ibuprofen to a higher risk of acute kidney injury.

What it does to the heart and blood vessels

The cardiovascular risks of NSAIDs prompted the U.S. Food and Drug Administration to strengthen its warnings on both prescription and over-the-counter products. The FDA has stated that non-aspirin NSAIDs can increase the chance of a heart attack or stroke, that the risk can begin within the first weeks of use, and that it may rise with longer use and higher doses. The agency also notes the risk appears in people with and without existing heart disease, though those with cardiovascular conditions or risk factors are more vulnerable. The mechanism is again tied to prostaglandins: by shifting the balance of the molecules that govern blood clotting, blood-vessel constriction and fluid retention, NSAIDs can raise blood pressure and promote clot formation. Ibuprofen at low doses is considered among the lower-risk options, but that advantage fades as the daily dose climbs above about 1,200 milligrams.

Why the danger is easy to overlook

Part of what makes chronic NSAID use hazardous is that the early damage produces few obvious symptoms. Declining kidney function often causes no noticeable signs until it is advanced, and the gradual rise in cardiovascular risk is invisible from day to day. Because ibuprofen is inexpensive, effective and available on any pharmacy shelf, people managing persistent conditions such as arthritis or chronic back pain may take it daily for months or years without medical oversight. Reviews of the topic describe the cardiovascular harms of NSAIDs as an under-recognized public health issue precisely because the drugs are so common and the risks accumulate silently. The quiet nature of the harm is what gives it the potential to go unnoticed until a serious event occurs.

Who faces the greatest risk

The evidence points consistently to certain groups for whom caution matters most. Older adults, whose kidney function naturally declines with age, are more susceptible to NSAID-related kidney injury. People with existing heart disease, high blood pressure, heart failure, chronic kidney disease or liver disease face compounded danger. So do those taking medicines that interact with NSAIDs, including some blood-pressure drugs and blood thinners. Health authorities generally advise that when NSAIDs are needed, they be used at the lowest effective dose for the shortest necessary time, and that people with these risk factors discuss alternatives with a clinician. For short-term relief of an occasional ache in an otherwise healthy adult, the risks remain small; it is the pattern of long-term, high-dose use that the research flags.

Putting the risk in perspective

None of this means ibuprofen is a dangerous drug in ordinary use. Taken as directed for limited periods, it remains a safe and valuable medicine for millions of people, and its anti-inflammatory power is genuinely useful. The point that emerges from decades of research and regulatory review is narrower: the safety profile changes with dose and duration. Sustained heavy use, especially in people already vulnerable to kidney or heart problems, shifts the balance toward harm in ways that often go undetected. Understanding that distinction allows the drug to be used where it helps while avoiding the slow, quiet toll that its overuse can exact.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.

More from Morning Overview